Company Filing History:
10 out of 344 
1 out of 362 
Years Active: 1976-1981
Title: The Innovative Contributions of George L Dunn
Introduction
George L Dunn is a notable inventor based in Wayne, PA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Dunn has made remarkable advancements, particularly in the development of cephalosporins, which are vital in combating bacterial infections.
Latest Patents
Among his latest patents, Dunn has developed compounds such as 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido], which features novel cephalosporins with improved antibacterial and pharmacokinetic properties. These compounds are characterized by a 2-alkoxyimino-2-(2-amino-4-thiazolyl)-acetamido group at position 7 and a sulfaminoalkyltetrazolythio group at position 3. Another significant patent is for 7-Alpha-oxyiminoacylcephalosporins, which describes new semisynthetic cephalosporins exhibiting antibacterial activity. The structures of these new compounds include an alpha-oxyimino group in the 7-acetamidomoiety along with a carboxyalkyltetrazolylthiomethyl group at position 3.
Career Highlights
Dunn has had a distinguished career, working with prominent companies such as SmithKline Corporation and Smith Kline & French Laboratories Limited. His work has significantly impacted the pharmaceutical industry, particularly in the development of antibiotics.
Collaborations
Throughout his career, Dunn has collaborated with esteemed colleagues, including John R Hoover and David A Berges. These partnerships have fostered innovation and contributed to the advancement of medical science.
Conclusion
George L Dunn's contributions to the field of pharmaceuticals through his innovative patents and collaborations have made a lasting impact on antibiotic development. His work continues to influence the industry and improve healthcare outcomes.